Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer

Rogier Butter, Nils A 't Hart, Gerrit K J Hooijer, Kim Monkhorst, Ernst-Jan Speel, Paul Theunissen, Erik Thunnissen, Jan H Von der Thüsen, Wim Timens, Marc J van de Vijver

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)423-430
Number of pages8
JournalJournal of Clinical Pathology
Volume73
Issue number7
Early online date10 Dec 2019
DOIs
Publication statusPublished - Jul 2020

Keywords

  • lung cancer
  • immunohistochemistry
  • oncology
  • pulmonary pathology
  • histopathology
  • SQUAMOUS-CELL
  • OPEN-LABEL
  • EXPRESSION
  • DOCETAXEL
  • PEMBROLIZUMAB
  • BLOCKADE
  • ASSAY
  • HETEROGENEITY
  • ATEZOLIZUMAB
  • NIVOLUMAB

Cite this

Butter, R., 't Hart, N. A., Hooijer, G. K. J., Monkhorst, K., Speel, E-J., Theunissen, P., Thunnissen, E., Von der Thüsen, J. H., Timens, W., & van de Vijver, M. J. (2020). Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer. Journal of Clinical Pathology, 73(7), 423-430. https://doi.org/10.1136/jclinpath-2019-205993